- Topic
20k Popularity
21k Popularity
141k Popularity
3k Popularity
18k Popularity
- Pin
- 🎉 Hey Gate Square friends! Non-stop perks and endless excitement—our hottest posting reward events are ongoing now! The more you post, the more you win. Don’t miss your exclusive goodies! 🚀
🆘 #Gate 2025 Semi-Year Community Gala# | Square Content Creator TOP 10
Only 1 day left! Your favorite creator is one vote away from TOP 10. Interact on Square to earn Votes—boost them and enter the prize draw. Prizes: iPhone 16 Pro Max, Golden Bull sculpture, Futures Vouchers!
Details 👉 https://www.gate.com/activities/community-vote
1️⃣ #Show My Alpha Points# | Share your Alpha points & gains
Post your - 🚀 ETH jumped to $4,600 this morning, up 8.69% in 24h!
Just shy of the $4,891 ATH—think it breaks through?
📍 Follow Gate_Square, vote and drop your reason.
🎁 4 winners split $100 Futures Voucher! - 💙 Gate Square #Gate Blue Challenge# 💙
Show your limitless creativity with Gate Blue!
📅 Event Period
August 11 – 20, 2025
🎯 How to Participate
1. Post your original creation (image / video / hand-drawn art / digital work, etc.) on Gate Square, incorporating Gate’s brand blue or the Gate logo.
2. Include the hashtag #Gate Blue Challenge# in your post title or content.
3. Add a short blessing or message for Gate in your content (e.g., “Wishing Gate Exchange continued success — may the blue shine forever!”).
4. Submissions must be original and comply with community guidelines. Plagiarism or re
Sanyuan Bio: Luxin Capital plans to reduce its stake in the company by no more than 3%.
Jin10 data reported on July 10th that Sanyuan Biotechnology announced that its shareholder, Luxin Capital, plans to reduce its holdings in the company by no more than 6 million shares via concentrated bidding and Block Trading within 3 months after 15 trading days from the date of the announcement, which does not exceed 3% of the total share capital after excluding the shares in the company's repurchase special securities account. The reason for the reduction is the company's operational development needs, and the reduction price will be determined based on market prices. Luxin Capital is not the company's controlling shareholder or actual controller, and this reduction will not lead to a change in the company's control or have a significant impact on the company's governance structure and sustainable operation.